Skip to main content

#161680

SAR-22-019F mouse line

Cat. #161680

SAR-22-019F mouse line

Cat. #: 161680

Availability: 3-4 weeks

Disease: Non-alcoholic fatty liver disease (NAFLD)

Model: Transgenic

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Devanand Sarkar

Institute: Virginia Commonwealth University

Primary Citation: Manna et al. Hepatology doi: 10.1002/hep32797 PMID: 36120720

Tool Details
Application Details
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Tool name: SAR-22-019F mouse line
  • Cancer: Carcinoma
  • Research fields: Cancer
  • Disease: Non-alcoholic fatty liver disease (NAFLD)
  • Model: Transgenic
  • Crispr: No
  • Description: Transgenic mouse with hepatocyte-specific overexpression of MDA-9 (Alb/MDA-9). Alb/MDA-9 allows analysis of the role of MDA-9 in HCC development and progression. Alb/MDA-9 allows analysis of the molecular mechanism by which MDA-9 promotes HCC. This mouse line will also be useful in analyzing the role of MDA-9 in other liver diseases such as fibrosis. Findings identify a novel role of MDA-9/SDCBP in hepatocarcinogenesis thereby establishing the rationale for using MDA-9 inhibitors for the...
  • Application: qPCR, western blotting, IHC, and single-cell RNA-seq
  • Genetic background: This Alb/MDA-9 transgenic mouse line in B6CBAF1 background was generated by directing the expression of C-terminal HA-tagged human MDA-9/SDCBP under an upstream enhancer region (–10400 to –8500) fused to the 335-bp core region of mouse albumin promoter.
  • Phenotype: Higher tumor burden in livers , increased levels of serum liver enzymes, aspartate aminotransferase (AST), and alanine aminotransferase (ALT) in Alb/MDA-9 mice after 32 weeks
  • Strain: B6CBAF1
  • Production details: This Alb/MDA-9 transgenic mouse line in B6CBAF1 background was generated by directing the expression of C-terminal HA-tagged human MDA-9/SDCBP under an upstream enhancer region (–10400 to –8500) fused to the 335-bp core region of mouse albumin promoter.

Application Details

  • Application: qPCR, western blotting, IHC, and single-cell RNA-seq

References

  • Manna et al. Hepatology doi: 10.1002/hep32797 PMID: 36120720

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.